TuisENOV • NYSE
add
Enovis Corp
Vorige sluiting
$44,77
Dagwisseling
$43,83 - $45,90
Jaarwisseling
$38,27 - $65,03
Markkapitalisasie
2,53 mjd USD
Gemiddelde volume
636,38 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 505,22 m | 21,00% |
Bedryfskoste | 291,70 m | 17,80% |
Netto inkomste | -31,52 m | -994,48% |
Netto winsgrens | -6,24 | -804,35% |
Wins per aandeel | 0,73 | 30,36% |
EBITDA | 77,06 m | 51,71% |
Effektiewe belastingkoers | 21,35% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 35,42 m | 10,26% |
Totale bates | 5,55 mjd | 26,11% |
Totale aanspreeklikheid | 2,22 mjd | 131,12% |
Totale ekwiteit | 3,33 mjd | — |
Uitstaande aandele | 55,88 m | — |
Prys om te bespreek | 0,75 | — |
Opbrengs op bates | 0,27% | — |
Opbrengs op kapitaal | 0,31% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -31,52 m | -994,48% |
Kontant van bedrywe | 53,56 m | 72,69% |
Kontant van beleggings | -58,42 m | -241,50% |
Kontant van finansiering | -148,00 k | 98,92% |
Netto kontantverandering | -3,63 m | -901,66% |
Beskikbare kontantvloei | -4,65 m | -107,05% |
Meer oor
Enovis is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world. Wikipedia
Gestig
1995
Hoofkwartier
Webwerf
Werknemers
6 550
